SEC Form 4 · accession 0001190938-16-000001
Immune Therapeutics, Inc. · IMUN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Aronstam
Officer — Chief Financial Officer
Period of report
Jun 30, 2016
Accepted (ET)
Jul 6, 2016 · 3:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001559356
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Warrant for Common Stock | $0.17 | Jun 30, 2016 | A | 100,000 | A | Jun 30, 2016 | Jun 29, 2021 | Common Stock | 100,000 | 425,000 | D |